Analysis of serum vitamin D levels and prognosis in stage III colon carcinoma patients treated with adjuvant FOLFOX+/- cetuximab chemotherapy (NCCTG N0147) (Alliance)
- Citation:
- J Clin Oncol vol 35 (15 suppl) abstr 3516
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3674
- Program:
- TRP
- Primary Committee:
- Correl Sci NOS
- Sec. Committees:
- GI
- Pharmas:
- Sanofi, Eli Lilly
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Frank A. Sinicrope Qian Shi Thomas C. Smyrk Richard M. Goldberg Erica N Heying Steven J. Cohen Sharlene Gill Morton S. Kahlenberg Suresh Nair Anthony Frank Shields Daniel J. Sargent Balkrishna N. Jahagirdar Michael N. Pollak Steven R. Alberts
- Networks:
- LAPS-MN026, LAPS-NY016, LAPS-OH007, MCRC, METROMIN
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: